UNSPSC 51312505: Spaglumic acid

This classification denotes a histamine-1 receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X81L78B3RB. European Medicines Agency schedules Spaglumic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10609MIG. Spaglumic acid generally arises in the molecular formula C11H16N2O8.

The term SPAGLUMIC ACID is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, no 10 1978, list 18.) Most nations schedule spaglumic acid under HS 29241900 and SITC 51471. As of Q4 2014, SPAGLUMIC ACID remains the US FDA Preferred Term for this commodity. Spaglumic acid bears US NLM identifiers UMLS ID C2348231 and NCI Concept Code C72084. SMILES: CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O.

UNSPSC 51312505 Spaglumic acid is a Commodity code that does not align with recent state and local procurement activity. The three most recent opportunities posted under or near this code — Seminole County's procurement of naloxone and drug deactivation systems, Texas HHS's request for information on direct-to-manufacturer prescription programs, and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products — involve finished pharmaceutical products, pharmacy benefit management infrastructure, and over-the-counter supplies rather than spaglumic acid or active pharmaceutical ingredients (APIs) in that chemical family. State and local governments appear to use this code designation inconsistently or incorrectly when tagging pharmaceutical procurement opportunities.

No recent state and local contract opportunities directly soliciting spaglumic acid or matching the Commodity code's intended scope are evident in the current posting activity. The mismatch between the code's chemical specificity and the broad pharmaceutical distribution and pharmacy management work actually appearing under it suggests limited or no direct procurement activity for this ingredient at the state and local level. Firms pursuing business in state and local pharmaceutical procurement would be better positioned by tracking higher-level UNSPSC families covering pharmaceutical distribution, pharmacy benefit management, or multi-source generic drug programs rather than monitoring this Commodity code.